Francis Alenghat (@alenghat) 's Twitter Profile
Francis Alenghat

@alenghat

investigative cardiologist | inflammation, atherosclerosis, & prevention @uchicago

ID: 47009719

linkhttp://alenghatlab.org calendar_today14-06-2009 01:59:45

3,3K Tweet

1,1K Followers

559 Following

Francis Alenghat (@alenghat) 's Twitter Profile Photo

Ultimate-DAPT further chips away at aspirin for CAD. One month dapt post PCI for ACS, then kept on *ticagrelor alone* has same MACE as ticag+asa, and less bleeding. #ACC24 thelancet.com/journals/lance…

University of Chicago Cardiology Fellowship (@uccardsfellows) 's Twitter Profile Photo

We had a wonderful Fellowship Welcome Party this weekend!! Fellows, faculty and families enjoyed great weather, yummy treats & fun times at the home of Parker Ward !

We had a wonderful Fellowship Welcome Party this weekend!! Fellows, faculty and families enjoyed great weather, yummy treats &amp; fun times at the home of <a href="/PWard35/">Parker Ward</a> !
University of Chicago Cardiology Fellowship (@uccardsfellows) 's Twitter Profile Photo

Congrats to 🅲🅰🆁🅳🅸🅰🅲 🅲🅻🅴🅰🆁🅰🅽🅲🅴 — our fellow-led volleyball team, finishing in the top 4 last season, and recently awarded a graduate medical education wellness grant to cover league registration fees. And yes, Chicago has beaches!

Congrats to 🅲🅰🆁🅳🅸🅰🅲 🅲🅻🅴🅰🆁🅰🅽🅲🅴 — our fellow-led volleyball team, finishing in the top 4 last season, and recently awarded a graduate medical education wellness grant to cover league registration fees.  

And yes, Chicago has beaches!
Francis Alenghat (@alenghat) 's Twitter Profile Photo

Join for the American College of Cardiology Heart Tank as Young Investigators pitch their Clinical Electrophysiology research ideas "Shark Tank" style. TOMORROW Nov 13, 7pm ET. #ACCAcademic acc.org/Education-and-…

Join for the <a href="/ACCinTouch/">American College of Cardiology</a> Heart Tank as Young Investigators pitch their Clinical Electrophysiology research ideas "Shark Tank" style. TOMORROW Nov 13, 7pm ET.  #ACCAcademic
acc.org/Education-and-…
Francis Alenghat (@alenghat) 's Twitter Profile Photo

#AHA24 BPROAD study - SBP target<120 vs <140 in pts with T2DM - achieved SBP 121 vs 132, and event rates 1.65 vs 2.09% per 100 person-years. nejm.org/doi/full/10.10…

#AHA24 BPROAD study - SBP target&lt;120 vs &lt;140 in pts with T2DM - achieved SBP 121 vs 132, and event rates 1.65 vs 2.09% per 100 person-years. nejm.org/doi/full/10.10…
Francis Alenghat (@alenghat) 's Twitter Profile Photo

#AHA24 SUMMIT trial - tirzepatide in obesity-related HFpEF - 731 pts total - 8% vs 14% worsening HF, and improved QOL, but no benefit for CV death. nejm.org/doi/full/10.10…

#AHA24 SUMMIT trial - tirzepatide in obesity-related HFpEF - 731 pts total - 8% vs 14% worsening HF, and improved QOL, but no benefit for CV death. 
nejm.org/doi/full/10.10…
Francis Alenghat (@alenghat) 's Twitter Profile Photo

#AHA24 OPTION trial - 1600 pts who had PVI for AF - randomized to left atrial appendage closure vs oral anticoagulation. nejm.org/doi/full/10.10…

#AHA24 OPTION trial - 1600 pts who had PVI for AF - randomized to left atrial appendage closure vs oral anticoagulation. nejm.org/doi/full/10.10…
Francis Alenghat (@alenghat) 's Twitter Profile Photo

#AHA24 clear synergy oasis 9 trial  - spironolactone at time of large MI - no difference in composite cv death, HF, or 2nd composite including MI, CVA as well. nejm.org/doi/full/10.10…

#AHA24 clear synergy oasis 9 trial  - spironolactone at time of large MI - no difference in composite cv death, HF, or 2nd composite including MI, CVA as well.   

nejm.org/doi/full/10.10…